Robert Weinstein is Chief Financial Officer of Synaptogenix, Inc.. Currently has a direct ownership of 33,198 shares of SNPX, which is worth approximately $98,266. The most recent transaction as insider was on Dec 16, 2022, when has been sold 27,000 shares (Common Stock, par value $0.0001 per share) at a price of $1.17 per share, resulting in proceeds of $31,589. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.2K
0% 3M change
0% 12M change
Total Value Held $98,266

ROBERT WEINSTEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2022
SELL
Open market or private sale
$31,589 $1.17 p/Share
27,000 Reduced 44.85%
33,198 Common Stock, par valu...
Jul 13 2021
BUY
Grant, award, or other acquisition
-
60,000 Added 49.92%
60,198 Common Stock, par valu...

Also insider at

XSPA
XpresSpa Group, Inc. Consumer Cyclical
PMCB
PharmaCyte Biotech, Inc. Healthcare
RW

Robert Weinstein

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on SNPX

Follow Synaptogenix, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNPX shares.

Notify only if

Insider Trading

Get notified when an Synaptogenix, Inc. insider buys or sells SNPX shares.

Notify only if

News

Receive news related to Synaptogenix, Inc.

Track Activities on SNPX